Allergan launches generic version of AstraZeneca cholesterol tablet
Pharmaceutical company Allergan has received approval from the US Food and Drug Administration to launch a generic version of a cholesterol drug owned by AstraZeneca.
Allergan received final approval on Monday, May 2, for its Abbreviated New Drug Application to market a generic of AstraZeneca’s Crestor (rosuvastatin) tablets.
Crestor is used to treat high cholesterol and to prevent cardiovascular disease.
Robert Stewart, Allergan's executive vice president, said: “This first-to-market launch demonstrates the talent of our generics team in developing, manufacturing and bringing to market high-quality, affordable versions of widely used medications like Crestor.
“This is expected to be the largest generic launch in 2016, benefiting patients and reducing cost for US health systems.”